QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CTKB

QT67Cytek Biosciences, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
3.77
-0.21-5.28%
OverviewShort InterestFilings
CTKBQT67Cytek Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
3.77-5.28%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-0.58
Insider Own10.01%
Shs Outstand129.14M
Perf Week-6.22%
Market Cap513.99MForward P/E-EPS next Y-0.27Insider Trans0.83%Shs Float-Perf Month5.60%
Enterprise Value484.65MPEG0.05EPS next Q-0.01Inst Own-Short Float-Perf Quarter-16.41%
Income-74271193.00P/S2.52EPS this Y39.66%Inst Trans-Short Ratio-Perf Half Y-19.79%
Sales204.17MP/B1.56EPS next Y23.81%ROA-16.48%Short Interest-Perf YTD-25.35%
Book/sh2.54P/C-EPS next 5Y-ROE-20.77%52W High6.18 -39.00%Perf Year18.18%
Cash/sh2.03P/FCF-EPS past 3/5Y-ROIC-11.42%52W Low2.90 30.00%Perf 3Y-
Dividend Est.-EV/EBITDA-21.88Sales past 3/5Y7.02% 16.67%Gross Margin51.70%Volatility3.83% 3.90%Perf 5Y-
Dividend TTM-EV/Sales2.37EPS Y/Y TTM-182.00%Oper. Margin-21.49%ATR (14)0.24Perf 10Y-
Dividend Ex-Date-Quick Ratio4.07Sales Y/Y TTM2.00%Profit Margin-36.25%RSI (14)40.18Recom2.60
Dividend Gr. 3/5Y-Current Ratio4.69EPS Q/Q-33.33%SMA20-7.04%Beta1.41Target Price5.13
Payout0.00%Debt/Eq0.11Sales Q/Q7.32%SMA50-11.06%Rel Volume13.69Prev Close3.98
Employees663LT Debt/Eq0.04EarningsAug 05SMA200-15.84%Avg Volume1.33MPrice3.77
IPO DateJul 23, 2021Option/ShortYes / YesEPS/Sales Surpr.-50.00% 0.00%Net Debt/EBITDA1.32Volume18,260,344Change-5.28%
Analyst Ratings
DateActionAnalystRatingTarget
May-13-26ReiteratedStephens$5.50 → $4.75
May-12-26ReiteratedMorgan StanleyEqual Weight$6.00 → $5.50
Dec-01-25ReiteratedMorgan StanleyEqual Weight$6.00
Mar-04-25ReiteratedPiper SandlerOverweight$8.50 → $8.00
Feb-02-25ReiteratedGoldman SachsBuy$4.50 → $5.25
May-13-24ReiteratedPiper SandlerOverweight$16 → $8.50
Latest News
Jun-15-26
Jun-15-2603:01PM
Cytek Biosciences, Inc. (CTKB) Presents at Singular Research's Las Vegas Invitational Conference - SlideshowSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue204201200
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A999789
Gross Profit106104111
Selling, General and Administrative Excl. Other11410892
Research and Development373639
Other Operating Expense-211
Operating Income-44-40-21
Interest Expense100
Unusual Expense
———
Non-Operating Income (Expense)-9-11-15
Net Income Before Taxes-36-30-6
Income Taxes38370
Consolidated Net Income-74-67-6
Net Income From Continuing Operations-74-67-6
Net Income-74-67-6
EPS (Recurring)-0.58-0.52-0.05
EPS (Basic, Before Extraordinaries)-0.58-0.52-0.05
EPS (Diluted)-0.58-0.52-0.05
EBITDA-21-175
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.383.22—
Gross Margin51.9651.7455.50
Operating Margin-21.57-19.90-10.50
Net Margin-36.27-33.33-3.00
Shares Outstanding129128131
Market Capitalization486646—
Operating Lease Expense
———
Insider Trading Volume
$3.95$3.56$3.17$2.78$2.39● Close Price0.00K24.32K48.65K72.97K97.30KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ball JackDirectorJun 10 '26Option Exercise0.0087,946086,678Jun 12 12:00 AM
Imper VeraDirectorJun 10 '26Option Exercise0.0087,946059,679Jun 12 12:00 AM
NEFF DEBORAH JDirectorJun 10 '26Option Exercise0.0087,946059,679Jun 12 12:00 AM
Holder MichaelDirectorJun 10 '26Option Exercise0.0087,946060,694Jun 12 12:00 AM
Holder MichaelDirectorMay 18 '26Option Exercise0.002,908016,721May 20 12:00 AM
Chin RichardDirectorMay 18 '26Option Exercise0.0012,214050,897May 20 12:00 AM
Yan MingCHIEF TECHNOLOGY OFFICERMay 18 '26Option Exercise0.0044,35804,934,944May 20 12:00 AM
Busque PhilippeSVP, GLOBAL SALES AND SERVICESMay 18 '26Option Exercise0.0020,9280127,675May 20 12:00 AM
Jiang WenbinPRESIDENT AND CEOMay 18 '26Option Exercise0.00160,12405,492,212May 20 12:00 AM
McCombe William D.Chief Financial OfficerMay 18 '26Option Exercise0.0051,4380246,091May 20 12:00 AM
Barnett ValerieCHIEF LEGAL OFFICERMay 18 '26Option Exercise0.0048,5900217,018May 20 12:00 AM
Chin RichardDirectorMar 10 '26Option Exercise0.0012,214057,004Mar 12 12:00 AM
Barnett ValerieCHIEF LEGAL OFFICERMar 10 '26Option Exercise0.0059,4440140,176Mar 12 12:00 AM
Busque PhilippeSVP, GLOBAL SALES AND SERVICESMar 10 '26Option Exercise0.0019,656043,505Mar 12 12:00 AM
Jiang WenbinPRESIDENT AND CEOMar 10 '26Option Exercise0.00167,68805,432,099Mar 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR